Japan-based medical and wellness brand KouShiCare has introduced its latest device, the LuminEyes Light Therapy Device, for advancing dry eye disease treatment.
The device leverages DWV Low-Level Laser Therapy (LLLT) technology, a new advancement in light-based ocular care.
Dry eye disease, which often leads to discomfort and blurred vision, has traditionally been treated with eye drops and medications offering only temporary relief.
The LuminEyes device employs LLLT and DWV LLLT technology to enhance cellular metabolism and tissue repair.
It uses low-power LEDs, delivering red or near-infrared light to biological tissues, which helps prevent thermal damage and improves overall eye health.
By targeting the eyelids and Meibomian glands with LEDs at wavelengths between 600nm and 900nm, the device stimulates ocular metabolism through photobiomodulation.
Research and clinical studies have shown that Red Light Therapy effectively softens blocked Meibomian gland lipids, improves the tear film’s lipid layer, and enhances tear film stability.
Compared to traditional treatments, the method provides more significant results with added convenience and comfort.
Designed for home use, the LuminEyes device offers several key features.
Users can expect noticeable improvements in dry eye conditions within 28 days, with a satisfaction guarantee offering a full refund if not satisfied within 30 days.
The patented DWV LLLT technology stimulates tear secretion, improves tear film stability.
It also provides anti-inflammatory effects while promoting tissue repair and enhancing blood circulation around the eyes.
The device is non-invasive, ensuring effective results without surgery or discomfort, and includes intelligent voice prompts and soothing music for a relaxing experience.
It also features an auto shut-off feature for safety, activating if not worn for five seconds or if the device temperature exceeds 47°C.
KouShiCare is offering the LuminEyes device exclusively through its online store.
